Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BMY
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bristol-Myers Squibb Co (BMY) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BMY trades at $67.92, up 0.95% today, near the consensus price target of $68.56. The stock shows strong fundamentals with a P/E of 14.88 and robust profitability, including a net income margin of 18.87%. Recent quarterly earnings have consistently beaten expectations, and technical indicators signal a bullish trend. However, the RSI suggests mild overbought conditions, and debt levels have risen, with a debt-to-asset ratio of 53.64% in 2024.
The outlook for BMY is positive, supported by earnings momentum and strategic collaborations like the AI-driven antibody discovery with Chai Discovery (Business Wire, 2026-08-20). Risks include competitive pressures in oncology and reliance on key drugs like Eliquis. Analysts are divided, with 48% recommending Buy, but the stock offers value with a dividend yield from recent payouts.
Read full analysis

Key Stats

  • Market Cap
    $138.03B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $67.92
  • 52W Low
    $42.60
  • Typical Hold Time
    -
  • Enterprise Value
    $172.01B
  • Div Yield
    3.73%
  • Trading Activity
    -
$66.85
52W Low: $42.6
29 Oct 2025
52W High: $67.92
25 Aug 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $67.92, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Most Recent News

Content is generated by Aura AI

Clearfield remains a buy despite FY2026 guidance cut due to broadband delays and fiber shortages.

Clearfield cut its FY2026 guidance because of delays in broadband projects linked to slow government BEAD program rollout and fiber supply constraints. However, the company secured a $22 million order for hyperscale data centers, validating its growt...

Market News
4 hours ago
Seeking Alpha
Neutral
pluang ai news

Xiaomi plans $29B R&D from 2026-2030 focusing on AI, chips, and smart ecosystem growth.

Xiaomi will invest $29 billion in research and development between 2026 and 2030, prioritizing advancements in custom artificial intelligence, chips, and operating systems. This investment aims to strengthen its Human x Car x Home ecosystem and boost...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

System1 rejects Brave Bison's takeover offer due to undervaluation and unchanged terms.

System1 Group has again rejected Brave Bison's takeover offer, citing that the terms remain unchanged and the offer undervalues System1's shares. Brave Bison's proposal values System1 shares at a discount of 8.2% to the current market price, which Sy...

Market News
4 hours ago
Proactive Investors
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $138.03B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $67.92
  • 52W Low
    $42.60
  • Typical Hold Time
    -
  • Enterprise Value
    $172.01B
  • Div Yield
    3.73%
  • Trading Activity
    -
$66.85
52W Low: $42.6
29 Oct 2025
52W High: $67.92
25 Aug 2026

Track Bristol-Myers Squibb Co (BMY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $67.92, highlighting its annual price range. Buy and sell Bristol-Myers Squibb Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!